Results 211 to 220 of about 16,889 (275)

Bilateral dyskinesias induced by unilateral subthalamic nucleus deep brain stimulation: A case report. [PDF]

Surg Neurol Int
Rosa MRF, Fidelis RL, Spitz M, Nigri F, Parise M.   +4 more
europepmc   +1 more source

Rare Abdominal Manifestations in a Patient with Parkinson's Disease after Deep Brain Stimulation of the Subthalamic Nucleus: A Case Report. [PDF]

Case Rep Neurol
Koyama H, Morigaki R, Miyake K, Matsuda T, Fujikawa J, Shinohara K, Nishida Y, Takagi Y.   +7 more
europepmc   +1 more source

Belly Dancer Dyskinesia: A Case Report and Review of Management. [PDF]

Cureus
Aboukar A, Ibrahim W.
europepmc   +1 more source

Effect on Dyskinesia of the Early Combination of Amantadine to Levodopa-Therapy in Parkinson's Disease: A Randomized, Placebo-Controlled Study (PREMANDYSK). [PDF]

Mov Disord
Rascol O, Ory-Magne F, Meissner WG, Maltête D, Defebvre L, Azulay JP, Thobois S, Houeto JL, Thalamas C, Sommet A, Geny C, Damier P, Anheim M, Marquès A, Viallet F, Giroud M, Lefaucheur R, Costentin G, Spampinato U, Samier-Foubert A, Carrière N, Mutez E, Mariani LL, Eusebio A, Prange S, Benatru I, Charif M, Brefel-Courbon C, Fabbri M, Galitzky M, Rousseau V, Saubion A, Catala H, Ferreira JJ, Burn DJ, Corvol JC, PREMANDYSK Study Group.   +36 more
europepmc   +1 more source

Personalized Treatments for Functional Disorders of the Sphincter of Oddi: A Short Muscle with a Long History of Discussion and Controversies. [PDF]

J Pers Med
Berger Z, Pap Á.
europepmc   +1 more source

ATG14-Mediated SNARE Complex Activation Promotes ΔFosB Degradation to Ameliorate Levodopa-Induced Dyskinesia. [PDF]

J Neurochem
Wu Y, Liu K, Zhang Z, Ma Z, Tang Z, Chang A, Ouyang H, Zhai H, Cao X, Xu Y.   +9 more
europepmc   +1 more source

Reporting Frequency of Antipsychotics-Induced Tardive Dyskinesia and Other Extrapyramidal Symptoms: Analysis Based on a Spontaneous Reporting System Database in Japan. [PDF]

Neuropsychopharmacol Rep
Saga Y, Horio H, Chiang CL, Wakamatsu A.
europepmc   +1 more source

Impact of Adjunctive Istradefylline on Dyskinesia Onset in Patients with Parkinson's Disease Exhibiting Wearing-Off: An Open-Label Randomized Controlled Trial. [PDF]

Neurol Ther
Tsuboi Y, Hasegawa T, Shimo Y, Kaneko S, Tomiyama M, Kashihara K, Chiu SW, Yamaguchi T, ODYSSEI study group.   +8 more
europepmc   +1 more source

Effects of chemogenetic inhibition of serotonergic raphe-striatal neurons on L-DOPA-induced behaviors and neurochemistry in a rat model of Parkinson's disease. [PDF]

Acta Neuropathol Commun
Budrow CN, Bernal-Conde LD, Sandoval IM, Galfano A, Grezenko H, Velazquez A, Marmion DJ, Flores-Barrera E, Venkatesh S, Coyle M, Meyers K, Nguyen K, Holden H, Tseng KY, Bishop CR, Manfredsson FP.   +15 more
europepmc   +1 more source